Broadwater Capital’s Exact Sciences EXAS Stock Holding History

Broadwater Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$305	–	213
2026 Q1	$305	Hold	3	–	–	﹤0.01%	209
2025 Q4	$305	Hold	3	–	–	﹤0.01%	209
2025 Q3	$164	Sell	3 -156	-98%	-$7.79K	﹤0.01%	216
2025 Q2	$159K	Buy	159 +156	+5,200%	+$7.92K	﹤0.01%	219
2025 Q1	$130	Hold	3	–	–	﹤0.01%	224
2024 Q4	$169	Hold	3	–	–	﹤0.01%	231
2024 Q3	$204	Hold	3	–	–	﹤0.01%	235
2024 Q2	$127	Hold	3	–	–	﹤0.01%	236
2024 Q1	$207	Hold	3	–	–	﹤0.01%	233
2023 Q4	$222	Buy	+3	New	+$197	﹤0.01%	222

Broadwater Capital's EXAS Position: Q2 2026 in Review

Broadwater Capital sold out of Exact Sciences (EXAS) in Q2 2026, closing a stake of 3 shares — an estimated $305 sold.

Broadwater Capital first reported a position in EXAS in Q4 2023 and held it in 10 quarters. The position peaked at $159K in Q2 2025. 0 funds tracked by Wall St. Rank hold EXAS as of Q2 2026.

Broadwater Capital reported no remaining Exact Sciences position as of Q2 2026 after selling out during the quarter.
Broadwater Capital sold 3 Exact Sciences shares in Q2 2026, an estimated $305.
Broadwater Capital first reported a position in Exact Sciences in Q4 2023 and held it in 10 quarters.
Broadwater Capital's Exact Sciences position peaked at $159K in Q2 2025.
0 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.